Histological and Histomorphometric Assessment With Inflammatory Profile Analysis of Bone Tissue After Horizontal Ridge Augmentation Using Customized Porous Zirconia Shell
Histological and Histomorphometric Assessment With Inflammatory Profile Analysis of Bone Tissue After Horizontal Ridge Augmentation of the Lower Posterior Mandible Using a Novel Customized Porous Zirconia Shell Technique: Clinical Case Study
The goal of this clinical study is to learn whether a custom-made porous zirconia shell can support good-quality new bone when widening the lower back jaw before dental implant placement. The study includes adults whose jawbone in this area is too narrow for implants (Seibert Class I defects).
The main question it aims to answer is: What is the quality of the new bone formed under a porous zirconia shell, and how much inflammation does the tissue show?
Participants will:
- Receive gum treatment and a CBCT scan before surgery
- Have bone augmentation surgery, in which a digitally designed porous zirconia shell is fixed over a mixture of their own bone and xenograft
- Return after 2 weeks for suture removal and a check of the wound
- Return after 6 months for a CBCT scan, removal of the shell, collection of a small bone sample (biopsy), and dental implant placement
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Horizontal bone loss in the posterior mandible often prevents dental implant placement. The Khoury technique uses thin autogenous cortical bone plates to rebuild the ridge, but harvesting these plates causes donor-site morbidity, is technically demanding, and is limited by available bone. Zirconia is biocompatible, mechanically strong and osteoconductive, and has shown low inflammatory response. However, it has not been studied as a shell replacing autogenous bone plates.
In this single-arm study, 10 adults with Seibert Class I defects in the posterior mandible will first receive non-surgical periodontal therapy. Compliance will be checked after 1 month. A zirconia shell with 1.5 mm pores will be digitally designed from each patient's CBCT scan, milled on a 5-axis machine, then cleaned and sterilized.
Under local anesthesia, buccal and lingual full-thickness flaps will be raised and the recipient bone decorticated. Autogenous bone chips will be harvested from the mandibular body with a bone chip maker and mixed 1:1 with xenograft. The shell will be fixed over the graft with 3-4 buccal screws. The flaps will be advanced and closed with a double-layer suture.
After 6 months, the shell will be removed, a core biopsy will be taken, and an implant will be placed. The biopsies will be fixed in 10% formalin and analyzed histologically, histomorphometrically and for tissue inflammatory response.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Mohammed Mahmoud Abed, BDS
- Telefoonnummer: 00201118322238
- E-mail: mohammed.mahmoud12@msa.edu.eg
Studie Contact Back-up
- Naam: Ahmed Reda Abd Elrahman, PhD
- Telefoonnummer: 00201206960001
- E-mail: arrahman@msa.edu.eg
Studie Locaties
-
-
Giza Governorate
-
Giza, Giza Governorate, Egypte
- Werving
- October University for Modern Sciences and Arts (MSA), Faculty of Dentistry
-
Contact:
- Mohammed Mahmoud Abed, BDS
- Telefoonnummer: 00201118322238
- E-mail: mohammed.mahmoud12@msa.edu.eg
-
Contact:
- Ahmed Reda Abd Elrahman, PhD
- Telefoonnummer: 00201206960001
- E-mail: arrahman@msa.edu.eg
-
Onderonderzoeker:
- Ahmed Reda Abd Elrahman, PhD
-
Hoofdonderzoeker:
- Mohammed Mahmoud Abed, BDS
-
Onderonderzoeker:
- Nada Abdelmonem Zazou, PhD
-
Onderonderzoeker:
- Mahmoud Ibrahim Nassar, PhD
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Age more than 21 years old
- Horizontal bone loss in the lower posterior area (Seibert Class I)
- Enough inter-arch space for placement of implant-supported prosthesis
- Motivated patient to have the treatment
- Good oral hygiene
Exclusion Criteria:
- Patients with systemic conditions that could interfere with the healing process
- Pregnant females
- Smokers
- Poor oral hygiene
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Customized Porous Zirconia Shell
Participants with horizontal bone defects in the posterior mandible receive ridge augmentation using a patient-specific porous zirconia shell fixed over a 1:1 mixture of autogenous bone and xenograft. After 6 months, the shell is removed, a bone biopsy is taken, and a dental implant is placed. |
A CAD/CAM-milled zirconia shell with 1.5 mm pores, designed from each patient's CBCT scan and fixed with 3-4 buccal screws over a 1:1 mix of autogenous bone chips and xenograft. It replaces the autogenous cortical plates used in the Khoury technique and is removed after 6 months. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Quality of Newly Formed Bone Assessed by Descriptive Histological Analysis of the Core Biopsy
Tijdsspanne: 6 months after ridge augmentation (at shell removal and implant placement)
|
Histological analysis of the core bone biopsy harvested from the augmented site. Specimens will be fixed in a 10% formalin solution. Descriptive analysis of the cells and tissue structure of the augmented site within the biopsy (Dellavia et al., 2021). |
6 months after ridge augmentation (at shell removal and implant placement)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Percentage of Newly Formed Bone (% of Total Biopsy Area)
Tijdsspanne: 6 months after augmentation
|
Histomorphometric measurement of the new bone area as a percentage of the total biopsy area. |
6 months after augmentation
|
|
Percentage of Residual Graft Material (% of Total Biopsy Area)
Tijdsspanne: 6 months after augmentation
|
Histomorphometric measurement of the remaining graft particle area as a percentage of the total biopsy area. |
6 months after augmentation
|
|
Percentage of Soft Tissue (% of Total Biopsy Area)
Tijdsspanne: 6 months after augmentation
|
Histomorphometric measurement of the non-mineralized connective tissue area as a percentage of the total biopsy area. |
6 months after augmentation
|
|
Inflammatory Cell Infiltration Score
Tijdsspanne: 6 months after augmentation
|
Semi-quantitative tissue response score from 0 (no inflammatory cells) to 4 (severe cellular infiltrate or tissue necrosis), based on the presence of lymphocytes, macrophages, foreign body giant cells, eosinophils and neutrophils. |
6 months after augmentation
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie directeur: Nada Abdelmonem Zazou, PhD, October University for Modern Sciences and Arts (MSA)
- Studie stoel: Ahmed Reda Abd Elrahman, PhD, October University for Modern Sciences and Arts (MSA)
- Studie directeur: Mahmoud Ibrahim Nassar, PhD, October University for Modern Sciences and Arts (MSA)
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- REC-D 6206-5
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Individual participant data will not be shared to protect patient confidentiality, as stated in the approved protocol. Study results will be published in a peer-reviewed dental journal.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .